Which of the following describes a significant change in the DSM-5 concerning substance-related disorders?

Which of the following describes a significant change in the DSM-5 concerning substance-related disorders?

• A. The expansion of the multi-axial system
• B. The restructuring of the global assessment functioning scale
• C. The removal of the distinction between abuse and dependence
• D. Development of new treatment guidelines

Answer: (C)

The removal of the distinction between abuse and dependence in the DSM-5 is a significant change that reflects a more nuanced understanding of substance use disorders. In previous editions, substance-related disorders were categorized into two separate diagnoses: substance abuse and substance dependence. This separation often led to confusion and missed some nuances of a person's relationship with substances. The DSM-5 introduces a single diagnosis of "substance use disorder" that encompasses a spectrum of severity, ranging from mild to severe, based on a combination of symptoms. This change acknowledges that substance use issues exist on a continuum and allows for a more comprehensive approach to diagnosis and treatment. It encourages clinicians to assess the severity of the disorder based on specific criteria rather than categorically labeling an individual as simply "abusing" or "dependent" on substances. This reclassification also facilitates better communication among healthcare providers and supports a more personalized treatment approach that considers individual experiences and needs, moving beyond binary labels that may not fully capture the complexities of a person's situation.

The removal of the distinction between abuse and dependence in the DSM-5 is a significant change that reflects a more nuanced understanding of substance use disorders. In previous editions, substance-related disorders were categorized into two separate diagnoses: substance abuse and substance dependence. This separation often led to confusion and missed some nuances of a person's relationship with substances.

The DSM-5 introduces a single diagnosis of "substance use disorder" that encompasses a spectrum of severity, ranging from mild to severe, based on a combination of symptoms. This change acknowledges that substance use issues exist on a continuum and allows for a more comprehensive approach to diagnosis and treatment. It encourages clinicians to assess the severity of the disorder based on specific criteria rather than categorically labeling an individual as simply "abusing" or "dependent" on substances.

This reclassification also facilitates better communication among healthcare providers and supports a more personalized treatment approach that considers individual experiences and needs, moving beyond binary labels that may not fully capture the complexities of a person's situation.